Board of Directors

Kenneth Anderson, MD

Harvard Medical School, Dana-Farber Cancer Institute

Eric Baum

Managing Director, Acquis Consulting Group + Solidea Capital

Moses Dodo

Director

Mohamad Hussein

Corporate Vice President: Global lead, Multiple Myeloma, Celgene (2008-2019, Retired)

Asher Chanan-Khan, MD

+ Chronic Lymphocytic Leukemia Lead
Professor of Medicine and Co-Chairman Hematologic Malignancies Program, Mayo Clinic Cancer Center – Jacksonville, Mayo Clinic Cancer Center

Pedro Lichtinger

Chairman & CEO

Nitin Kaushal

Director

Fotios Plakogiannis

Managing Director of Transdermal Research Pharm Laboratories (TRPL)

Roy F Waldron

Senior VP Associate General Counsel & Chief Intellectual Property Counsel, Pfizer Inc. (Retired June, 2018)